| Analysis of PIK3CA mutations and activation pathways in triple negative breast cancer P Cossu-Rocca, S Orrù, MR Muroni, F Sanges, G Sotgiu, S Ena, G Pira, ... PloS one 10 (11), e0141763, 2015 | 108 | 2015 |
| Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients SAM Urru, S Gallus, C Bosetti, T Moi, R Medda, E Sollai, A Murgia, ... BMC cancer 18, 1-11, 2018 | 102 | 2018 |
| HLA-DQB1* 0201 homozygosis predisposes to severe intestinal damage in celiac disease RD Jores, F Frau, F Cucca, M Grazia Clemente, S Orrù, M Rais, ... Scandinavian journal of gastroenterology 42 (1), 48-53, 2007 | 76 | 2007 |
| Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis FC Geyer, M Lacroix‐Triki, PE Colombo, N Patani, A Gauthier, R Natrajan, ... Histopathology 60 (6B), E115-E130, 2012 | 61 | 2012 |
| miRNA-135b contributes to triple negative breast cancer molecular heterogeneity: Different expression profile in basal-like versus non-basal-like phenotypes P Uva, P Cossu-Rocca, F Loi, G Pira, L Murgia, S Orrù, M Floris, ... International Journal of Medical Sciences 15 (6), 536, 2018 | 36 | 2018 |
| Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis F Sanges, M Floris, P Cossu-Rocca, MR Muroni, G Pira, SAM Urru, ... BMC cancer 20, 1-14, 2020 | 28 | 2020 |
| Colorectal cancer early detection in stool samples tracing CpG islands methylation alterations affecting gene expression AF Vega-Benedetti, E Loi, L Moi, S Orrù, P Ziranu, A Pretta, E Lai, ... International Journal of Molecular Sciences 21 (12), 4494, 2020 | 27 | 2020 |
| A role of BRCA1 and BRCA2germline mutations in breast cancer susceptibility within Sardinian population G Palomba, A Loi, A Uras, P Fancello, G Piras, A Gabbas, A Cossu, ... BMC cancer 9, 1-10, 2009 | 23 | 2009 |
| Modulatory role of microRNAs in triple negative breast cancer with basal-like phenotype A Angius, P Cossu-Rocca, C Arru, MR Muroni, V Rallo, C Carru, P Uva, ... Cancers 12 (11), 3298, 2020 | 19 | 2020 |
| Acute liver failure because of Wilson disease with overlapping autoimmune hepatitis features: the coexistence of two diseases? G Loudianos, A Zappu, MB Lepori, V Dessì, E Mameli, S Orrù, RA Podda, ... Journal of Pediatric Gastroenterology and Nutrition 63 (2), e23-e24, 2016 | 9 | 2016 |
| Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype A Angius, G Pira, P Cossu-Rocca, G Sotgiu, L Saderi, MR Muroni, P Virdis, ... Journal of Cancer Research and Clinical Oncology 149 (7), 3951-3963, 2023 | 8 | 2023 |
| Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon … AF Vega-Benedetti, E Loi, L Moi, A Restivo, F Cabras, S Deidda, A Pretta, ... Human Cell, 1-10, 2022 | 8 | 2022 |
| Interleukin-3-receptor-α in triple-negative breast cancer (TNBC): an additional novel biomarker of TNBC aggressiveness and a therapeutic target M Koni, I Castellano, E Venturelli, A Sarcinella, T Lopatina, C Grange, ... Cancers 14 (16), 3918, 2022 | 7 | 2022 |
| Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey N Fusco, M Ivanova, C Frascarelli, C Criscitiello, B Cerbelli, MG Pignataro, ... Critical Reviews in Oncology/Hematology, 104103, 2023 | 4 | 2023 |
| Prognostic role of androgen receptor expression in HER2+ breast carcinoma subtypes S Orrù, E Pascariello, G Sotgiu, D Piras, L Saderi, MR Muroni, C Carru, ... Biomedicines 10 (1), 164, 2022 | 4 | 2022 |
| Systemic mastocytosis with associated primary myelofibrosis M Greco, G Caocci, R Mascia, S Nemolato, M Deidda, MP Simula, ... Indian Journal of Hematology and Blood Transfusion 36, 442-443, 2020 | 2 | 2020 |
| The role of MicroRNAs as early biomarkers of asbestos-related lung cancer: A systematic review and meta-analysis D Mukhopadhyay, P Cocco, S Orrù, R Cherchi, S De Matteis Pulmonology, 2024 | | 2024 |
| Biomarker dynamics affecting neoadjuvant therapy response and outcome of HER2-positive breast cancer subtype S Orrù, E Pascariello, B Pes, V Rallo, R Barbara, M Muntoni, F Notari, ... Scientific Reports 13 (1), 12869, 2023 | | 2023 |
| Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group B Meduri, F De Rose, C Cabula, I Castellano, L Da Ros, MM Grassi, ... Medical Oncology 38 (6), 67, 2021 | | 2021 |
| PO-1277: Network of Radiotherapy Cancer Centers in Sardinia: equipment, staff and access to care S Campoccia, E Orefici, R Barbara, F Cabras, S Loi, P Marini, S Orrù, ... Radiotherapy and Oncology 152, S673, 2020 | | 2020 |
